Journal
FUTURE ONCOLOGY
Volume 4, Issue 4, Pages 535-551Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/14796694.4.4.535
Keywords
diagnosis; fine-needle biopsy; histopatholopy; melanoma; prognosis; sentinel lymph node; staging; ultrasound
Categories
Funding
- Sydney Alelanonta Unit
- Department of Anatomical Pathology
- Royal Prince Alfied Hospital, Sydney, Australia
Ask authors/readers for more resources
Sentinel lymph node (SLN) biopsy affords an accurate, minimally invasive means of staging and determining prognosis in patients with melanoma and for identifying those patients who may benefit from complete regional lymph node dissection. Careful and accurate histopathologic assessment of SLNs is critical to achieving optimal reliability of the technique. Micromorphometric parameters of melanoma deposits in SLNs have been shown to be predictive of regional non-SLN involvement and of clinical outcomes. Several non-histopathologic methods of SLN evaluation have been investigated, and while some of them show promise for the future, excision and histopathologic examination currently remains the gold standard for the evaluation of SLNs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available